loading...| Preferred Name |
Kaposi Sarcoma |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C9087 |
| ALT_DEFINITION |
A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally. |
| code |
C9087 |
| Concept_In_Subset | |
| Contributing_Source |
CTRP |
| DEFINITION |
A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS). |
| Display_Name |
Kaposi Sarcoma |
| FULL_SYN |
KS Multiple Hemorrhagic Sarcoma Kaposi's Sarcoma |
| ICD-O-3_Code |
9140/3 |
| label |
Kaposi Sarcoma |
| Legacy_Concept_Name |
Kaposi_s_Sarcoma |
| Neoplastic_Status |
Malignant |
| Preferred_Name |
Kaposi Sarcoma |
| prefixIRI |
C9087 |
| prefLabel |
Kaposi Sarcoma |
| Semantic_Type |
Neoplastic Process |
| UMLS_CUI |
C0036220 |
| subClassOf |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C8538 |